TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34010110

Group type: EXPERIMENTAL
Intervention: 8-week pilot intuitive eating intervention delivered through group and guided self-help
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Group modality
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Guided self-help modality
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both modalities
Number of subjects: 71
Study: 32877258

Group type: EXPERIMENTAL
Intervention: 3-hour problem-solving, Story-bridge mental health literacy programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33512629

Group type: EXPERIMENTAL
Intervention: Underbody blanket
Number of subjects: 99

Group type: COMPARATOR
Intervention: Overbody blanket
Number of subjects: 99
Study: 33382378

Group type: COMPARATOR
Intervention: Website (level 1)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Website and personalized diet and exercise prescription (level 2)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Website, personalized prescription, Fitbit, and text messages (level 3)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Website, personalized prescription, Fitbit, text messages, and 2 phone calls (level 4)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Level 4 vs Level 1
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Website visit frequency
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Follow-up rates
Number of subjects: 202
Study: 36482844

Group type: EXPERIMENTAL
Intervention: Hypopressive exercises
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 117
Study: 34418964

Group type: EXPERIMENTAL
Intervention: Digital decision support system for GPs
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Medication plans and discussions with GPs
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Healthcare provider interactions
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Personal experiences with medications
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 13
Study: 33086749

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 240 U
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 360 U
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 35258115

Group type: EXPERIMENTAL
Intervention: CBLO-TTT
Number of subjects: 12

Group type: COMPARATOR
Intervention: CBLO
Number of subjects: 12

Group type: COMPARATOR
Intervention: TTT
Number of subjects: 12
Study: 32228137

Group type: EXPERIMENTAL
Intervention: Expert Feedback (EF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Expert plus Help Screen (EF + HS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Augmented visual (HS)
Number of subjects: 36
Study: 35124615

Group type: EXPERIMENTAL
Intervention: Digital group (CAD/CAM digital implant guide)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (traditional impression)
Number of subjects: 42
Study: 33486138

Group type: EXPERIMENTAL
Intervention: EEG-based brain training (n1 = 21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional treatment (active control group, n2 = 20)
Number of subjects: 41
Study: 36353274

Group type: EXPERIMENTAL
Intervention: Post-MS (Salat after meals)
Number of subjects: 30
Study: 36202649

Group type: EXPERIMENTAL
Intervention: Thyroid hormone replacement therapy
Number of subjects: 235

Group type: COMPARATOR
Intervention: Hashimoto thyroiditis diagnosis
Number of subjects: 235

Group type: COMPARATOR
Intervention: Multivariate analysis of Hashimoto thyroiditis
Number of subjects: 235
Study: 35267967

Group type: EXPERIMENTAL
Intervention: Symbiotic nutritional supplement (daily mixture of symbiotics, omega-3/6 fatty acids, and amino acids)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32674103

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (SO) prior to NIV
Number of subjects: 380

Group type: COMPARATOR
Intervention: No supplemental oxygen (SO) prior to NIV
Number of subjects: 380
Study: 36309756

Group type: EXPERIMENTAL
Intervention: Gibbs Framework
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GRIPP-2(SF) checklist
Number of subjects: 0
Study: 34161586

Group type: EXPERIMENTAL
Intervention: JUUL System (5.0% and 3.0% nicotine concentrations)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: JUUL System (Dual-Use group with 5.0% nicotine)
Number of subjects: 279

Group type: COMPARATOR
Intervention: UB Cigarette group
Number of subjects: 279

Group type: COMPARATOR
Intervention: Abstinence group
Number of subjects: 279
Study: 32938569

Group type: EXPERIMENTAL
Intervention: Tivozanib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study: 33683087

Group type: EXPERIMENTAL
Intervention: Topical imiquimod 5% cream
Number of subjects: 103
Study: 35745100

Group type: EXPERIMENTAL
Intervention: Low Physical Activity (PA) group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Medium Physical Activity (PA) group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: High Physical Activity (PA) group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 57
Study: 33858395

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction for Teens (MBSR-T)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as Usual Control (CTRL)
Number of subjects: 40
Study: 32712173

Group type: EXPERIMENTAL
Intervention: 21% oxygen
Number of subjects: 22

Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 22
Study: 34803132

Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Monthly anti-VEGF injections
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Anti-VEGF every three months
Number of subjects: 40
Study: 34411597

Group type: EXPERIMENTAL
Intervention: Non-animal stabilized hyaluronic acid/dextranomer gel (Deflux; NASHA/Dx)
Number of subjects: 0
Study: 32908192

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 506
Study: 33543264

Group type: EXPERIMENTAL
Intervention: Placebo-controlled diagnostic blocks
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Fully randomized, placebo-controlled, triple blocks
Number of subjects: 206
Study: 32975679

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 34042006

Group type: EXPERIMENTAL
Intervention: Self-selected power and prescribed cadence of 80 revolutions per minute
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prescribed power of 100 W and self-selected cadence
Number of subjects: 24
Study: 34236705

Group type: EXPERIMENTAL
Intervention: R15 method (three-pass, one-session procedure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 0
Study: 32739563

Group type: EXPERIMENTAL
Intervention: Question Prompt List (QPL)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study: 32185417

Group type: EXPERIMENTAL
Intervention: Community participation programme based on the ecosystem model
Number of subjects: 1812

Group type: COMPARATOR
Intervention: Usual official prevention programs (Control)
Number of subjects: 1812

Group type: EXPERIMENTAL
Intervention: Community participation programme
Number of subjects: 1812
Study: 33276944

Group type: EXPERIMENTAL
Intervention: Re-experiencing polygenic risk score (PRS)
Number of subjects: 2030

Group type: EXPERIMENTAL
Intervention: Secure attachment style
Number of subjects: 2030

Group type: EXPERIMENTAL
Intervention: Insecure attachment style
Number of subjects: 2030

Group type: EXPERIMENTAL
Intervention: PRS and attachment style interaction
Number of subjects: 2030

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analyses
Number of subjects: 2030

Group type: EXPERIMENTAL
Intervention: Attachment style and IGSF11 gene variant (rs151177743)
Number of subjects: 2030
Study: 34654579

Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention (consultation with a general practitioner)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention (communication of personal benefits only)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention (communication of personal and collective benefits)
Number of subjects: 507
Study: 33959179

Group type: EXPERIMENTAL
Intervention: Comprehensive care program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 60
Study: 32069126

Group type: EXPERIMENTAL
Intervention: Etonogestrel-releasing subdermal implant
Number of subjects: 103

Group type: COMPARATOR
Intervention: 52-mg levonorgestrel-releasing intrauterine system
Number of subjects: 103
Study: 36371675

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia (propofol maintenance)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Inhalation anesthesia (sevoflurane maintenance)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Emergence delirium
Number of subjects: 175
Study: 33414377

Group type: EXPERIMENTAL
Intervention: Moderate Intensity Training (MIT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sprint Intensity Training (SIT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both MIT and SIT
Number of subjects: 22
Study: 36271356

Group type: EXPERIMENTAL
Intervention: Laser guiding navigation device
Number of subjects: 32

Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 32
Study: 33459901

Group type: EXPERIMENTAL
Intervention: Skeletal-related events (SRE) patients
Number of subjects: 9832

Group type: COMPARATOR
Intervention: Non-skeletal-related events (non-SRE) patients
Number of subjects: 9832
Study: 34435212

Group type: EXPERIMENTAL
Intervention: Ostomy Self-Management Telehealth (OSMT)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 118
Study: 32609532

Group type: EXPERIMENTAL
Intervention: Sustained hypoxia (SH)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 35
Study: 35412685

Group type: EXPERIMENTAL
Intervention: N. sativa oil (two capsules of 500 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (two capsules of 500 mg mineral oil)
Number of subjects: 50
Study: 34314574

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (10 mg/day for creatinine clearance ≥50 ml/min; 7.5 mg/day for ≥30-<50 ml/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivaroxaban and Placebo
Number of subjects: 0
Study: 35871989

Group type: EXPERIMENTAL
Intervention: Coaching Group
Number of subjects: 49

Group type: COMPARATOR
Intervention: No Coaching Group
Number of subjects: 49
Study: 34570899

Group type: EXPERIMENTAL
Intervention: Combined blast and blunt head trauma
Number of subjects: 190

Group type: COMPARATOR
Intervention: Blunt trauma only
Number of subjects: 190

Group type: COMPARATOR
Intervention: Blast trauma only
Number of subjects: 190
Study: 36008267

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 1498

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 1498
Study: 35468455

Group type: EXPERIMENTAL
Intervention: ALARA approach
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 61
Study: 32032641

Group type: EXPERIMENTAL
Intervention: Online group including IUD users
Number of subjects: 488

Group type: COMPARATOR
Intervention: Control group including nine IUD non-users
Number of subjects: 488
Study: 34056945

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) combined with high-density fat transplantation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional fat-granule transplantation (control group)
Number of subjects: 70
Study: 33428798

Group type: EXPERIMENTAL
Intervention: Continuous maize cultivation for 1-9 years in areas surrounding problem fields
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous maize cultivation from 2003 to 2018
Number of subjects: 0

Group type: COMPARATOR
Intervention: Geospatial analysis of land use patterns
Number of subjects: 0
Study: 36171515

Group type: EXPERIMENTAL
Intervention: IV golimumab 80 mg/m2 at weeks 0, 4, then every 8 weeks (Q8W)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: SC ustekinumab at weeks 0, 4, then Q12W (dosing based on weight)
Number of subjects: 127
Study: 34622669

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 26024

Group type: COMPARATOR
Intervention: Bare-Metal Stents (BMS)
Number of subjects: 26024
Study: 32629662

Group type: EXPERIMENTAL
Intervention: Yizhi Qingxin Decoction (YQD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ginkgo biloba extract tablets
Number of subjects: 100
Study: 32930627

Group type: EXPERIMENTAL
Intervention: TCHMC 200 g per day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: TCHMC 300 g per day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (0 g TCHMC per day)
Number of subjects: 18
Study: 33397121

Group type: EXPERIMENTAL
Intervention: Mendelian randomization approach
Number of subjects: 0
Study: 35997868

Group type: EXPERIMENTAL
Intervention: Facility-based HIV testing augmented with free HIV self-testing (HIVST)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Facility-based HIV testing
Number of subjects: 230
Study: 34433576

Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS) above the medial prefrontal cortex (mPFC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 103
Study: 35083623

Group type: EXPERIMENTAL
Intervention: Group A: video laryngoscopes with a self‐equipped stylet for tube preshaping
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Group B: curvature of the video laryngoscope blade is modelled for tube preshaping
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Group C: tube preshaping angle consistent with the video laryngoscope blade, bending point set 1 cm above the tracheal tube cuff
Number of subjects: 300

Group type: COMPARATOR
Intervention: Group A
Number of subjects: 300

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 300
Study: 34244277

Group type: EXPERIMENTAL
Intervention: Guided self-help intervention (EG) based on Acceptance and Commitment Therapy (ACT), comprising an introduction and seven modules (one module per week, processing time about 45-60 min).
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist control group (CG).
Number of subjects: 42
Study: 35176765

Group type: EXPERIMENTAL
Intervention: Presence of gastrointestinal (GI) symptoms in adults (34.1%)
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Higher hemoglobin A1c (HbA1c) levels in patients with GI symptoms (68 ± 14mmol/mol; 8.35 ± 1.37%)
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Microvascular complications (nephropathy, retinopathy, and/or neuropathy)
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Presence of autoimmune conditions (including thyroid and biopsy‐confirmed celiac disease)
Number of subjects: 2370
Study: 33678469

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 266

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 266
Study: 32184007

Group type: EXPERIMENTAL
Intervention: Pectoral nerve (Pecs) II block under general anesthesia (PG group)
Number of subjects: 196

Group type: COMPARATOR
Intervention: General anesthesia alone (G group)
Number of subjects: 196
Study: 36151754

Group type: EXPERIMENTAL
Intervention: OSCE group (n=19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (n=19)
Number of subjects: 38
Study: 33615395

Group type: EXPERIMENTAL
Intervention: Basal diet + 0.15 mg Se/kg (NS-Gly)
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Basal diet + 0.30 mg Se/kg (NS-Gly)
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Basal diet + 0.45 mg Se/kg (NS-Gly)
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Basal diet + 0.60 mg Se/kg (NS-Gly)
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Basal diet + 0.30 mg Se/kg (Na2SeO3)
Number of subjects: 864

Group type: COMPARATOR
Intervention: Basal diet (control, 0.13 mg Se/kg)
Number of subjects: 864
Study: 33142505

Group type: EXPERIMENTAL
Intervention: Natural astaxanthin (ASTA) 25 mg/kg
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Natural astaxanthin (ASTA) 50 mg/kg
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Natural astaxanthin (ASTA) 100 mg/kg
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control (0 mg/kg ASTA)
Number of subjects: 288
Study: 36052911

Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional vein harvest technique
Number of subjects: 80
Study: 33316237

Group type: EXPERIMENTAL
Intervention: Single-limb LLHR-RT
Number of subjects: 33

Group type: COMPARATOR
Intervention: Two-limb LLHR-RT
Number of subjects: 33
Study: 36129031

Group type: EXPERIMENTAL
Intervention: Methohexital (0.5 mg/kg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Propofol (0.8 mg/kg)
Number of subjects: 70
Study: 33153433

Group type: EXPERIMENTAL
Intervention: Negative age stereotype priming (n=53)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Neutral words priming (n=52)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Social participation (moderating factor)
Number of subjects: 105
Study: 35614276

Group type: EXPERIMENTAL
Intervention: A-PRF+
Number of subjects: 16

Group type: COMPARATOR
Intervention: Blood clot (Control)
Number of subjects: 16
Study: 32739493

Group type: EXPERIMENTAL
Intervention: In-person advance care planning (ACP) discussions via face-to-face visits with a nurse facilitator following the Respecting Choices® Conversation Guide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Web-based ACP using the PREPARE for your care™ web-based ACP tool
Number of subjects: 0
Study: 32557166

Group type: EXPERIMENTAL
Intervention: Ultra-low dose CT (ULDCT)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Contrast-enhanced CT (CECT)
Number of subjects: 325
Study: 35709575

Group type: EXPERIMENTAL
Intervention: Extended training (ET)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Extended training with significant other (ETwSO)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: All training conditions
Number of subjects: 321
Study: 32472340

Group type: EXPERIMENTAL
Intervention: Essix retainers
Number of subjects: 35

Group type: COMPARATOR
Intervention: Hawley retainers
Number of subjects: 35

Group type: COMPARATOR
Intervention: Comparison between Essix and Hawley retainers
Number of subjects: 35
Study: 36494702

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (n=112)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Standard care (n=107)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Exploratory analysis
Number of subjects: 219
Study: 32556518

Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 IU/day
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU/day
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Vitamin D3 10,000 IU/day
Number of subjects: 302
Study: 35221758

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 μg/kg
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 32028459

Group type: EXPERIMENTAL
Intervention: HRRT-2 (2 days per week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HRRT-3 (3 days per week)
Number of subjects: 0
Study: 32759621

Group type: EXPERIMENTAL
Intervention: Ileal ulcers >2 cm
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Rectal ulcers >2 cm
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Deep ileal ulcers >2 cm
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Deep rectal ulcers >2 cm
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: High baseline Simple Endoscopic Score for CD (≥16) or CDEIS scores (≥12)
Number of subjects: 172
Study: 35172663

Group type: EXPERIMENTAL
Intervention: Vitamin E + Omega 3 supplementation for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33722073

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy plus fluoxetine
Number of subjects: 153

Group type: COMPARATOR
Intervention: Cognitive behavioural therapy plus placebo
Number of subjects: 153
Study: 32785972

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of nitric oxide synthase inhibitor NG‐monomethyl‐l‐arginine (l‐NMMA, 5 mg kg−1 bolus & subsequent 50 μg kg−1 min−1 maintenance dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Isovolumic haemodilution (20% of whole blood removed and replaced with 5% human serum albumin)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Phenylephrine infusion (0.1–0.6 μg kg−1 min−1 constant infusion)
Number of subjects: 18
Study: 32197901

Group type: EXPERIMENTAL
Intervention: Anticoagulation at discharge
Number of subjects: 166747

Group type: COMPARATOR
Intervention: Amiodarone use at discharge without anticoagulation
Number of subjects: 166747
Study: 32144499

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model with VGG16 architecture
Number of subjects: 68

Group type: COMPARATOR
Intervention: Traditional machine learning method using Support Vector Machine (SVM)
Number of subjects: 68
Study: 35902979

Group type: EXPERIMENTAL
Intervention: PL‐MSCs intravenous injection (1 × 10^6 cells/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standard treatment + PL‐MSCs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 20
Study: 33231127

Group type: EXPERIMENTAL
Intervention: Triggered monitoring (risk-based monitoring method)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Centralised processes for detecting or preventing findings
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Informed consent processes
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Use of electronic health records
Number of subjects: 312
Study: 33039490

Group type: EXPERIMENTAL
Intervention: Crossroads (2001-2003)
Number of subjects: 5258

Group type: EXPERIMENTAL
Intervention: Crossroads-II (2016-2018)
Number of subjects: 5258